[Jeon Hwa-sung's Startup Morning Coffee Ep. 1086] Total Immersion for Success: Stick to One Well

Every morning, the YouTube program 'Startup Morning Coffee,' which injects fresh vitality into the startup ecosystem, comes to viewers hosted by CEO Jeon Hwa-sung. Broadcast live at 8:40 AM on the 'Jeon Hwa-sung's CNTV' channel, this program deeply illuminates the innovative technologies and market potential of various startups, and has established itself as a platform providing valuable information and inspiration through real-time communication for those interested in startups. One of the companies recently highlighted on 'Startup Morning Coffee' is the healthcare startup 'Onjeonhi.' They present an innovative approach to alleviate the pain and discomfort of diagnosing complications, especially for diabetic patients suffering from chronic diseases. Moving away from traditional invasive and painful blood test methods, they are dedicated to developing a non-invasive solution that easily and painlessly measures and diagnoses key indicators of diabetic complications. Onjeonhi's ultimate goal is to dramatically improve the quality of life for suffering patients. Currently, they are accelerating their technological advancement with the support of CNT Tech's sports accelerating program. Onjeonhi's core competitiveness stems from the synergy between its 'non-invasive blood viscosity measurement technology' and the 'AI-based diagnostic algorithm' that supports it. Patients can undergo testing by simply collecting a small amount of blood from a fingertip capillary. This process is virtually painless, and the viscosity of the collected blood is precisely measured using Onjeonhi's proprietary technology. The data thus obtained is analyzed through an advanced AI algorithm to predict the risk of diabetic complications and provide accurate diagnoses. This provides patients with a convenient and rapid testing experience without the pain of repeated blood draws, and offers timely and accurate diagnostic information to medical staff, greatly assisting in setting treatment directions. CEO Jeon Hwa-sung commented on Onjeonhi's vision and technology, stating, "'Onjeonhi presents an innovative paradigm of non-invasive diagnosis and possesses unique potential in the explosively growing global chronic disease diagnostic market.'" Especially as the number of diabetic patients worldwide is rapidly increasing, and the early detection and management of related complications become more crucial than ever, Onjeonhi's diagnostic solution, combining convenience and accuracy, is expected to secure a strong competitive advantage in the global healthcare market. In this way, 'Startup Morning Coffee' discovers and highlights innovative startups like Onjeonhi, contributing to the development of a healthy startup ecosystem.